ArticleToxins2026
Analysis of the Combined Toxic Effects of AFB1, DON, and OTA Complex Contamination in Caco-2, HK-2, SK-N-SH and HepG2 Cells.
Article in Toxins, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Article
- Pollution characteristics, enrichment patterns, and progress in detoxification research of mycotoxins in maize.Mycotoxin research · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Aflatoxin B1 (AFB1), deoxynivalenol (DON), and ochratoxin A (OTA) are common mycotoxins that frequently co-occur in cereals and pose potential risks to animal and human health. This study investigated the cytotoxic effects of AFB1, DON, and OTA, individually and in binary and ternary combinations, in four human-derived cell lines representing major target organs (Caco-2, HepG2, HK-2, and SK-N-SH). Individual toxin exposure revealed cell type-dependent sensitivity, with DON generally exhibiting the strongest cytostatic effect. Combined exposure analysis showed distinct interaction patterns across cell models, including antagonistic effects of AFB1 + OTA in most cell lines, dose-dependent interactions of DON + OTA, and low-dose synergistic effects in specific combinations. Overall, the results demonstrate that mycotoxin interactions are highly dependent on dose and target cell type, and that low-dose co-contamination may enhance toxicological risks, underscoring the importance of considering combined mycotoxin exposure in health risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.